placeholder newsslider

The European Vision Institute EEIG

European Alliance for the Promotion of Vision Research and Ophthalmology

Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.

The Importance of EVI

The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.

Vision Research in Europe

SIFG „New Technologies for Outcome Measures in Retina and Glaucoma”

Meeting of the European Vision Institute - Special Interest Focus Group „New Technologies for Outcome Measures in Retina and Glaucoma” in Basel, Switzerland from 08. - 09. November 2018 Read more

Alcon Retina Fellows Institute launched to provide retinal surgery training

The unique educational offering supports retina fellows during a weekend-long training at the Alcon Experience Center in Fort Worth, Texas. Read more

Modeling the most common form of vision loss in older adults

Age-related macular degeneration (AMD) affects roughly 200,000 individuals in the United States each year. Read more

Why a postdoc might not advance your career

Two studies reiterate that very few postdoctoral researchers land academic posts — and suggest that the skills postdocs learn are not sought by employers outside academia. Read more

FDA Approves First Intracanalicular Dexamethasone Ophthalmic Insert for Post-Ocular Surgery

The approval of the DEXTENZA insert for surgical ocular pain was based on four phase Phase 3 studies one Phase 2 study for efficacy and safety. Read more

vision-research.eu

The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.

The Vision Awards

An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.

Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.

Ophthalmic Research

Ophthalmic Research - The Journal for Translational and Clinical Research is official affiliated with the European Vision Institute